| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.057 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |